Copyright © 2001 by the European Society of Cardiology.
Editorials
Every piece is important to build a puzzle. What can we learn from early experiences with balloon PTCA?
Hospital Santa Cruz, Lisbon, Portugal
References
- van Domburg RT, Foley DP, de Feyter PJ. Longterm clinical outcome after coronary balloon angioplasty: Identification of a population at low risk of recurrent events during 17 years of follow-up. Eur Heart J. 2001;22:934–941
[Abstract/Free Full Text] - Williams DO, Holubkov R, Yeh W. Percutaneous Coronary intervention in the current era compared with 1985–1986. The National Heart, Lung, and Blood Institute Registries. Circulation. 2000;102:2945–2951
[Abstract/Free Full Text] - Serruys PW, de Jaegere P, Kiemeneij F. A comparison of ballooon expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489–495
[Abstract/Free Full Text] - Fischman DL, Leon MB, Baim DS. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496–501
[Abstract/Free Full Text] - Leon MB, Baim DS, Popma JJ. A clinical trial comparing three anti-thrombotic drug regimens after coronary artery stenting: stent anticoagulation restenosis study. N Engl J Med. 1998;339:1665–1671
[Abstract/Free Full Text] - van Domburg RT, Foley DP, de Jaegere PPT. Long term outcome after coronary stent implantation: a 10 year single center experience of 1000 patients. Heart. 1999;82:1127–1134
- Karam C, Fajadet J, Beauchet A. Nine-year follow-up of balloon-expandable Palmaz-Schatz stent in patients with single-vessel disease. Cathet Cardiovasc Intervent. 2000;50:170–174[CrossRef][Web of Science][Medline]
- King SB, Kosinski AS, Guyton RA. Eight-year mortality in the Emory Angioplasty Versus Surgery Trial (EAST). J Am Coll Cardiol. 2000;35:1116–1121
[Abstract/Free Full Text] - J Am Coll Cardiol. 2000;35:1122–1129
[Abstract/Free Full Text] - Kuntz RE. Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy. The diabetes-percutaneous transluminal coronary angioplasty dilemma. Circulation. 1999;99:847–851
[Free Full Text]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R J van der Schaaf, J R Timmer, J P Ottervanger, J C A Hoorntje, M-J de Boer, H Suryapranata, F Zijlstra, and J-H E Dambrink Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy Heart, December 1, 2006; 92(12): 1760 - 1763. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||